Developer docs
API playgroundTry for free, no card

Search company profiles

UterineKind

Full company profile

uuid003lw9z

Namestring
UterineKind
Legal namestring
UterineKind, Inc.
Websiteurl
uterinekind.com
Company typeenum
Private
Founded yearint
2022
Descriptiontext

UterineKind is a Boston-based, privately held digital health company founded in January 2022 by Carol Johnson after pivoting from her prior creative agency (Advocats Agency). The company targets individuals — primarily women and adolescent girls — whose symptoms of chronic gynecologic conditions (endometriosis, fibroids, PCOS, PMDD, adenomyosis, AUB, chronic pelvic pain, pelvic inflammatory disease, uterine prolapse) are dismissed or underdiagnosed by traditional healthcare providers. The stated goal is to compress a diagnostic timeline that typically runs years into a 100-day engagement window.

The company's product surface is built on a proprietary mobile and Progressive Web Application offering structured daily symptom tracking across six categories (Pain, Mental Health, Body, Sleep, Energy, Bleeding) with four severity levels and detailed sub-symptoms, an automated physician-ready symptom summary report generator, a private health diary, and an in-app educational content library. The app is paired with a paid 100-day care navigation program staffed by Board Certified Patient Advocates (BCPAs), which provides education, physician referrals to vetted specialists, weekly check-ins, unlimited chat, and HIPAA-compliant communications. The platform is HIPAA-, GDPR-, and CCPA-compliant, uses Stripe for payments, and is distributed via the Apple App Store and a web app. Adjacent offerings include the Hello Uterus podcast (an educational sub-brand) and a donation-funded menstrual health education program (10% of all revenue is allocated to female/reproductive health research).

The business model is freemium: the app is free with no paywalls or advertising and serves as the top-of-funnel acquisition channel, while the BCPA care program is the sole monetized product and is sold direct-to-consumer via the company website on a multi-year subscription structure (HSA/FSA eligible). UterineKind is bootstrapped and founder-owned with no disclosed venture funding, operates with a team of 1–10, and is supported by formal partnerships with the Lujan Laboratory at Cornell, the Metz-Gregersen Laboratory at the Feinstein Institutes for Medical Research, and senior medical advisors from Keck School of Medicine USC, Massachusetts General Hospital, and the University of Maryland School of Medicine.

Short descriptiontext

UterineKind is a Boston-based digital health company offering a free symptom-tracking app and a paid 100-day care navigation program led by Board Certified Patient Advocates, serving women whose chronic gynecologic conditions have been dismissed or underdiagnosed.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersBoston, United States
HQ citystring
Boston
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
symptom tracking software, patient care navigation, women's health platform, gynecology care coordination, chronic condition management
Industry2 codes
PRIMARYHLACANAK
Women’s Health & Fertility Therapeutics (Digital)
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
SECONDARYHLALAHAA
Fertility & Reproductive Endocrinology Telehealth (IVF/IUI, infertility evaluation)
Healthcare & Life Sciences/Telehealth Platforms/Women’s & Family Health Telehealth Platforms (fertility, pregnancy, pediatrics)
NAICS code1 code
  • Family Planning Centers621410
SIC code1 code
  • Services-Health Services8000
Product category
Digital Health Platform
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Care Navigation Program Subscription
TypeSubscription Recurring
Description

The 100-day Board Certified Patient Advocate (BCPA) care navigation program is the primary paid product. Includes BCPA consultations, care coordination, physician vetting and referral services, and 1-year app access. Program is HSA/FSA eligible for reimbursement.

uterinekind.com
2Mobile Application (Free)
TypeFreemium
Description

Core mobile application is provided free of charge with no paywalls or advertisements. Serves as the primary acquisition and engagement channel for the paid care program.

uterinekind.com
3Diagnostic Services Coordination
TypeProfessional Services
Description

BCPAs assist in identifying cost-effective diagnostic services (labs, imaging), negotiating cash-pay rates, and maximizing insurance coverage, though diagnostic tests themselves are not included in the program fee

uterinekind.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Others
Pricing details2 tiers
1Free Mobile App
ModelFreemiumBilling cadenceOthers
Notes

100% free to use with no paywalls, no ads. Includes symptom tracking, diary, educational library content, and symptom summary report generation.

uterinekind.com
2100-Day BCPA Care Navigation Program
ModelSubscriptionBilling cadenceMulti-year contract
Notes

Paid care navigation program including Board Certified Patient Advocate support for 100 days, unlimited app access, 2 additional check-in calls, weekly chat check-ins, unlimited chat questions, physician referral to vetted specialists, and HIPAA-compliant communications. Pricing not publicly disclosed.

uterinekind.com
GTM typeB2C
B2C
Offering typeServices
Services
Brand1 record
1Hello Uterus Podcast
Description

A podcast featuring episodes discussing reproductive health topics, featuring interviews with physicians, researchers, and patients on conditions like endometriosis, fibroids, PCOS, and reproductive justice.

uterinekind.com
Core offering1 text field

UterineKind is a direct-to-consumer women's health platform that combines a free mobile and Progressive Web App for daily symptom tracking with a paid 100-day Board Certified Patient Advocate (BCPA) care navigation subscription. The platform helps women with chronic gynecologic conditions document symptoms, generate structured reports for clinical visits, and receive personalized advocacy and care coordination from credentialed patient advocates.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

UterineKind offers a two-product platform: the UterineKind App (a free symptom-tracking and educational mobile/PWA tool) and the UterineKind Care Program (a paid 100-day advocate-led care navigation service). These products work together — the app provides ongoing symptom monitoring and education while the Care Program offers intensive BCPA support, physician referrals, and structured guidance over 100 days. The company also produces the Hello Uterus Podcast as an educational resource and operates a donation program for menstrual health education.

Product and service2 records
1UterineKind Symptom Tracking App
CategoryDigital Health Tool
2UterineKind BCPA Care Navigation Program
CategoryPatient Care Navigation Service
Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership5 partners
1Lujan Laboratory at Cornell University
Strategic tierCoreTypeStrategic or Co-development Partner
Description

UterineKind Partner Lab investigating the link between nutrition, metabolism and reproductive physiology in females, with particular expertise in Polycystic Ovarian Syndrome (PCOS). Marla Lujan, Ph.D. serves as Principal Investigator and Associate Professor of Human Nutrition. The partnership supports research funding and scientific collaboration.

2Metz-Gregersen Laboratory at Feinstein Institutes for Medical Research
Strategic tierCoreTypeStrategic or Co-development Partner
Description

UterineKind Partner Lab conducting the ROSE Study (Research Outsmarts Endometriosis). Led by Christine Metz, Ph.D. and Peter Gregersen, MD. The partnership funds endometriosis research and supports the scientific community working on this condition.

Strategic tierSupportingTypeStrategic or Co-development Partner
Description

Dr. Evelyn Nicole Mitchell serves as Senior Medical Advisor, holding positions as Clinical Assistant Professor of Obstetrics and Gynecology and Director of Diversity, Equity, and Inclusion of Obstetrics and Gynecology at Keck School of Medicine, USC.

Strategic tierSupportingTypeStrategic or Co-development Partner
Description

Dr. John Petrozza serves as Senior Medical Advisor. He is a Reproductive Endocrinologist and Reproductive Surgeon, Chief of Division of Reproductive Medicine and IVF, and Director of Massachusetts General Fertility Center, and Co-Director of the MGH Integrated Fibroid Program.

Strategic tierSupportingTypeStrategic or Co-development Partner
Description

Dr. Irina Burd serves as Medical Content Reviewer. She is Professor and Chair of the Department of Obstetrics, Gynecology and Reproductive Sciences at the University of Maryland, Baltimore.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Kindbody is a fertility and reproductive health company with clinics and virtual care spanning fertility, gynecology, and wellness. Relevant given UterineKind's reproductive endocrinology medical advisory and addressable audience of women with fertility-impacting conditions.

TypeBroad incumbent
Description

Tia operates a women's health platform combining virtual and in-person care with a focus on whole-person gynecology, mental health, and primary care. Comparable to UterineKind in addressing dismissed women's health symptoms, but with brick-and-mortar clinics and broader scope.

TypeDirect peer
Description

Clue is a leading period and cycle tracking app with evidence-based content and a subscription tier. It competes head-to-head with the UterineKind app for symptom-tracking share, especially among users seeking physician-shareable data.

TypeDirect peer
Description

Wisp provides direct-to-consumer telehealth for women's reproductive health, including UTI, STI, and contraception care. Comparable to UterineKind in D2C women's telehealth and addressing symptoms that are commonly dismissed or undertreated.

TypeEmerging player
Description

Mahmee is a maternal and infant health platform offering care navigation and in-person support for pregnancies and postpartum. It overlaps with UterineKind's care navigation model and audience of women with chronic gynecologic conditions that often intersect with maternal health.

TypeDirect peer
Description

Flo is the largest period and symptom tracking app globally, with a freemium model and premium AI insights. It directly overlaps with UterineKind's free symptom-tracking mobile app and competes for the same audience of women tracking reproductive health symptoms.

TypeBroad incumbent
Description

Maven is a large virtual-care platform for women's and family health with employer and payer contracts. It is a broader incumbent offering care navigation and specialist access across fertility, maternity, and gynecology, directly comparable to UterineKind's BCPA-led care navigation model.

TypeBroad incumbent
Description

Hers is a scaled direct-to-consumer women's telehealth and wellness brand. It competes for the same consumer acquisition channels and overlapping use cases (contraception, PCOS, hormonal health), making it a broad incumbent peer for UterineKind's D2C model.

TypeEmerging player
Description

Elektra Health is a women's health platform focused on menopause care navigation with clinician and community support. It is an emerging peer with a similar care-navigation-plus-education model, though focused on a different life stage than UterineKind.

TypeDirect peer
Description

Twentyeight Health is a telehealth platform delivering women's reproductive and sexual health care, including contraception, with a strong focus on underserved populations. Comparable to UterineKind in providing accessible women's telehealth plus care navigation.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration1 record

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

UterineKind

Digital Health Platformuterinekind.com

UterineKind is a Boston-based digital health company offering a free symptom-tracking app and a paid 100-day care navigation program led by Board Certified Patient Advocates, serving women whose chronic gynecologic conditions have been dismissed or underdiagnosed.

What UterineKind does

UterineKind is a Boston-based, privately held digital health company founded in January 2022 by Carol Johnson after pivoting from her prior creative agency (Advocats Agency). The company targets individuals — primarily women and adolescent girls — whose symptoms of chronic gynecologic conditions (endometriosis, fibroids, PCOS, PMDD, adenomyosis, AUB, chronic pelvic pain, pelvic inflammatory disease, uterine prolapse) are dismissed or underdiagnosed by traditional healthcare providers. The stated goal is to compress a diagnostic timeline that typically runs years into a 100-day engagement window.

The company's product surface is built on a proprietary mobile and Progressive Web Application offering structured daily symptom tracking across six categories (Pain, Mental Health, Body, Sleep, Energy, Bleeding) with four severity levels and detailed sub-symptoms, an automated physician-ready symptom summary report generator, a private health diary, and an in-app educational content library. The app is paired with a paid 100-day care navigation program staffed by Board Certified Patient Advocates (BCPAs), which provides education, physician referrals to vetted specialists, weekly check-ins, unlimited chat, and HIPAA-compliant communications. The platform is HIPAA-, GDPR-, and CCPA-compliant, uses Stripe for payments, and is distributed via the Apple App Store and a web app. Adjacent offerings include the Hello Uterus podcast (an educational sub-brand) and a donation-funded menstrual health education program (10% of all revenue is allocated to female/reproductive health research).

The business model is freemium: the app is free with no paywalls or advertising and serves as the top-of-funnel acquisition channel, while the BCPA care program is the sole monetized product and is sold direct-to-consumer via the company website on a multi-year subscription structure (HSA/FSA eligible). UterineKind is bootstrapped and founder-owned with no disclosed venture funding, operates with a team of 1–10, and is supported by formal partnerships with the Lujan Laboratory at Cornell, the Metz-Gregersen Laboratory at the Feinstein Institutes for Medical Research, and senior medical advisors from Keck School of Medicine USC, Massachusetts General Hospital, and the University of Maryland School of Medicine.

UterineKind firmographics

Firmographics
Name
UterineKind
Legal name
UterineKind, Inc.
Website
https://uterinekind.com
Company type
Private
Founded year
2022
Operating status
Operating
Headcount range
1–10 employees
Short description
UterineKind is a Boston-based digital health company offering a free symptom-tracking app and a paid 100-day care navigation program led by Board Certified Patient Advocates, serving women whose chronic gynecologic conditions have been dismissed or underdiagnosed.
Ownership category
akta.pro rank

UterineKind industry classification

Industry
Product category
Digital Health Platform
NAICS
Family Planning Centers (621410)
SIC
Services-Health Services (8000)
akta.pro industry
PRIMARYHLACANAK
Women’s Health & Fertility Therapeutics (Digital)
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
SECONDARYHLALAHAA
Fertility & Reproductive Endocrinology Telehealth (IVF/IUI, infertility evaluation)
Healthcare & Life Sciences/Telehealth Platforms/Women’s & Family Health Telehealth Platforms (fertility, pregnancy, pediatrics)

Keywords

  • Symptom tracking software
  • Patient care navigation
  • Women's health platform
  • Gynecology care coordination
  • Chronic condition management

Where UterineKind is headquartered

Location

Headquarters

HQ city
Boston
HQ country
United States
HQ region
North America

Offices1 record

Markets served

UterineKind business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Others

Revenue model

  1. Care Navigation Program Subscription: The 100-day Board Certified Patient Advocate (BCPA) care navigation program is the primary paid product. Includes BCPA consultations, care coordination, physician vetting and referral services, and 1-year app access. Program is HSA/FSA eligible for reimbursement.
  2. Mobile Application (Free): Core mobile application is provided free of charge with no paywalls or advertisements. Serves as the primary acquisition and engagement channel for the paid care program.
  3. Diagnostic Services Coordination: BCPAs assist in identifying cost-effective diagnostic services (labs, imaging), negotiating cash-pay rates, and maximizing insurance coverage, though diagnostic tests themselves are not included in the program fee

Pricing tiers

ModelBillingPrice
FreemiumOthersFree Mobile App
SubscriptionMulti-year contract100-Day BCPA Care Navigation Program

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

UterineKind product offering

Product offering

Core offering

UterineKind is a direct-to-consumer women's health platform that combines a free mobile and Progressive Web App for daily symptom tracking with a paid 100-day Board Certified Patient Advocate (BCPA) care navigation subscription. The platform helps women with chronic gynecologic conditions document symptoms, generate structured reports for clinical visits, and receive personalized advocacy and care coordination from credentialed patient advocates.

Product overview

UterineKind offers a two-product platform: the UterineKind App (a free symptom-tracking and educational mobile/PWA tool) and the UterineKind Care Program (a paid 100-day advocate-led care navigation service). These products work together — the app provides ongoing symptom monitoring and education while the Care Program offers intensive BCPA support, physician referrals, and structured guidance over 100 days. The company also produces the Hello Uterus Podcast as an educational resource and operates a donation program for menstrual health education.

Differentiator

Problem solved

Functional benefit

Brands

  • Hello Uterus Podcast: A podcast featuring episodes discussing reproductive health topics, featuring interviews with physicians, researchers, and patients on conditions like endometriosis, fibroids, PCOS, and reproductive justice.

Products and services

  • UterineKind Symptom Tracking App
  • UterineKind BCPA Care Navigation Program

Companies that use UterineKind

Customer profile

Named customers2 records

Segments3 records

Ideal customer profiles1 record

UterineKind technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration1 record

Feature4 records

UterineKind partnerships and signals

Strategic signal

Partnerships

Five partnerships are on record, tiered core and supporting.

  • Lujan Laboratory at Cornell UniversitycoreStrategic or Co-development PartnerUterineKind Partner Lab investigating the link between nutrition, metabolism and reproductive physiology in females, with particular expertise in Polycystic Ovarian Syndrome (PCOS). Marla Lujan, Ph.D. serves as Principal Investigator and Associate Professor of Human Nutrition. The partnership supports research funding and scientific collaboration.
  • Metz-Gregersen Laboratory at Feinstein Institutes for Medical ResearchcoreStrategic or Co-development PartnerUterineKind Partner Lab conducting the ROSE Study (Research Outsmarts Endometriosis). Led by Christine Metz, Ph.D. and Peter Gregersen, MD. The partnership funds endometriosis research and supports the scientific community working on this condition.
  • Keck Medicine of USCsupportingStrategic or Co-development PartnerDr. Evelyn Nicole Mitchell serves as Senior Medical Advisor, holding positions as Clinical Assistant Professor of Obstetrics and Gynecology and Director of Diversity, Equity, and Inclusion of Obstetrics and Gynecology at Keck School of Medicine, USC.
  • Massachusetts General HospitalsupportingStrategic or Co-development PartnerDr. John Petrozza serves as Senior Medical Advisor. He is a Reproductive Endocrinologist and Reproductive Surgeon, Chief of Division of Reproductive Medicine and IVF, and Director of Massachusetts General Fertility Center, and Co-Director of the MGH Integrated Fibroid Program.
  • University of Maryland School of MedicinesupportingStrategic or Co-development PartnerDr. Irina Burd serves as Medical Content Reviewer. She is Professor and Chair of the Department of Obstetrics, Gynecology and Reproductive Sciences at the University of Maryland, Baltimore.

Scale indicators3 records

Recent moves6 records

Expansion highlights6 records

UterineKind competitors and assessment

Company assessment

Broad incumbents

  • Kindbody: Kindbody is a fertility and reproductive health company with clinics and virtual care spanning fertility, gynecology, and wellness. Relevant given UterineKind's reproductive endocrinology medical advisory and addressable audience of women with fertility-impacting conditions.
  • Tia: Tia operates a women's health platform combining virtual and in-person care with a focus on whole-person gynecology, mental health, and primary care. Comparable to UterineKind in addressing dismissed women's health symptoms, but with brick-and-mortar clinics and broader scope.
  • Maven Clinic: Maven is a large virtual-care platform for women's and family health with employer and payer contracts. It is a broader incumbent offering care navigation and specialist access across fertility, maternity, and gynecology, directly comparable to UterineKind's BCPA-led care navigation model.
  • Hims & Hers (Hers): Hers is a scaled direct-to-consumer women's telehealth and wellness brand. It competes for the same consumer acquisition channels and overlapping use cases (contraception, PCOS, hormonal health), making it a broad incumbent peer for UterineKind's D2C model.

Direct peers

  • Clue: Clue is a leading period and cycle tracking app with evidence-based content and a subscription tier. It competes head-to-head with the UterineKind app for symptom-tracking share, especially among users seeking physician-shareable data.
  • Wisp: Wisp provides direct-to-consumer telehealth for women's reproductive health, including UTI, STI, and contraception care. Comparable to UterineKind in D2C women's telehealth and addressing symptoms that are commonly dismissed or undertreated.
  • Flo Health: Flo is the largest period and symptom tracking app globally, with a freemium model and premium AI insights. It directly overlaps with UterineKind's free symptom-tracking mobile app and competes for the same audience of women tracking reproductive health symptoms.
  • Twentyeight Health: Twentyeight Health is a telehealth platform delivering women's reproductive and sexual health care, including contraception, with a strong focus on underserved populations. Comparable to UterineKind in providing accessible women's telehealth plus care navigation.

Emerging players

  • Mahmee: Mahmee is a maternal and infant health platform offering care navigation and in-person support for pregnancies and postpartum. It overlaps with UterineKind's care navigation model and audience of women with chronic gynecologic conditions that often intersect with maternal health.
  • Elektra Health: Elektra Health is a women's health platform focused on menopause care navigation with clinician and community support. It is an emerging peer with a similar care-navigation-plus-education model, though focused on a different life stage than UterineKind.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

UterineKind social profiles

Digital presence

UterineKind compliance and trust

Trust signal

Compliance3 records

UterineKind financial estimates

Financial estimate

Revenue estimate

Valuation estimate

UterineKind leadership team

Management profile

Number of profiles

Profiles5 records

UterineKind funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

UterineKind M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about UterineKind

What does UterineKind do?

UterineKind is a direct-to-consumer women's health platform that combines a free mobile and Progressive Web App for daily symptom tracking with a paid 100-day Board Certified Patient Advocate (BCPA) care navigation subscription. The platform helps women with chronic gynecologic conditions document symptoms, generate structured reports for clinical visits, and receive personalized advocacy and care coordination from credentialed patient advocates.

Is UterineKind a public or private company?

UterineKind is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was UterineKind founded?

UterineKind was founded in 2022. It employs 1 to 10 people.

Where is UterineKind based?

UterineKind is headquartered in Boston, United States, in the North America region.

How does UterineKind make money?

Three revenue lines are on record. Care Navigation Program Subscription is the primary driver. The others are mobile Application (Free) and diagnostic Services Coordination.

Who are UterineKind's main competitors?

Broad incumbents on record are Kindbody, Tia, Maven Clinic and Hims & Hers (Hers). Direct peers are Clue, Wisp, Flo Health and Twentyeight Health. Emerging players are Mahmee and Elektra Health.

Does UterineKind have an API?

No public API is recorded for UterineKind.

What industry is UterineKind in?

UterineKind's product category is Digital Health Platform. Its primary akta.pro industry code is HLACANAK, Women’s Health & Fertility Therapeutics (Digital), with a secondary code of HLALAHAA, Fertility & Reproductive Endocrinology Telehealth (IVF/IUI, infertility evaluation). Its NAICS code is 621410 and its SIC code is 8000.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales